| |
Latest 10 SEC filings (by transaction date) for TVTX within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 12/24 | Apr 11/24 | Cline Christopher R. | Direct Ownership | Common Stock | S - Open market or private sale | -54 | $6.74 |
Feb 2/24 | Feb 1/24 | Dube Eric M | Direct Ownership | Common Stock | S - Open market or private sale | -10,016 | $8.86 |
Feb 2/24 | Feb 1/24 | Dube Eric M | Direct Ownership | Common Stock | S - Open market or private sale | -9,106 | $8.53 |
Feb 2/24 | Feb 1/24 | Rote William E. | Direct Ownership | Common Stock | S - Open market or private sale | -2,590 | $8.86 |
Feb 2/24 | Feb 1/24 | Rote William E. | Direct Ownership | Common Stock | S - Open market or private sale | -2,174 | $8.53 |
Feb 2/24 | Feb 1/24 | Reed Elizabeth E | Direct Ownership | Common Stock | S - Open market or private sale | -2,590 | $8.86 |
Feb 2/24 | Feb 1/24 | Reed Elizabeth E | Direct Ownership | Common Stock | S - Open market or private sale | -2,174 | $8.53 |
Feb 2/24 | Feb 1/24 | Heerma Peter | Direct Ownership | Common Stock | S - Open market or private sale | -4,195 | $8.53 |
Feb 2/24 | Feb 1/24 | Inrig Jula | Direct Ownership | Common Stock | S - Open market or private sale | -2,174 | $8.53 |
Feb 2/24 | Feb 1/24 | Cline Christopher R. | Direct Ownership | Common Stock | S - Open market or private sale | -3,818 | $8.53 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for TVTX within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 12/24 | Apr 11/24 | Cline Christopher R. | Direct Ownership | Common Stock | S - Open market or private sale | -54 | $6.74 |
Feb 2/24 | Jan 31/24 | Dube Eric M | Direct Ownership | Employee stock option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 360,000 | |
Feb 2/24 | Feb 1/24 | Dube Eric M | Direct Ownership | Common Stock | S - Open market or private sale | -10,016 | $8.86 |
Feb 2/24 | Feb 1/24 | Dube Eric M | Direct Ownership | Common Stock | S - Open market or private sale | -9,106 | $8.53 |
Feb 2/24 | Jan 31/24 | Dube Eric M | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 135,000 | |
Feb 2/24 | Jan 31/24 | Rote William E. | Direct Ownership | Employee stock option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 65,000 | |
Feb 2/24 | Feb 1/24 | Rote William E. | Direct Ownership | Common Stock | S - Open market or private sale | -2,590 | $8.86 |
Feb 2/24 | Feb 1/24 | Rote William E. | Direct Ownership | Common Stock | S - Open market or private sale | -2,174 | $8.53 |
Feb 2/24 | Jan 31/24 | Rote William E. | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 25,000 | |
Feb 2/24 | Jan 31/24 | Reed Elizabeth E | Direct Ownership | Employee stock option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 65,000 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |
Madrigal Pharmaceuticals (OQ:MDGL) |